Advancements and Insights in Non–Muscle-Invasive Bladder Cancer: Emerging PD-1/PD-L1 Inhibitors : Episode 1
Exploring NMIBC: Overview, Symptoms, Risk Factors and Staging
Panelists discuss how non–muscle-invasive bladder cancer (NMIBC) presents with specific symptoms and diagnostic procedures, emphasize the significant economic burden on health care systems, and highlight key risk factors like smoking and occupational exposure while also addressing the critical importance of accurate staging for guiding treatment decisions and the potential consequences of incorrect staging on patient outcomes.
Video content above is prompted by the following:
- What is non–muscle-invasive bladder cancer (NMIBC)?
- What are the common symptoms and signs of NMIBC?
- What diagnostic procedures are typically used to confirm a case of NMIBC?
- What is the economic burden of this disease for health care systems and insurance companies?
- What are the main risk factors associated with the development of NMIBC? Grabe-Heyne 2023
- Smoking as a risk factor for the development of bladder cancer
- Occupational risk factors
- No clear genetic association (that we know of so far)
- What are the different stages and grades of NMIBC?Grabe-Heyne 2023
- What is the importance of getting the stage correct? (PMID 38994181)
- Ensuring appropriate treatment based on patient stage
- How often do you feel that patients are incorrectly staged? How does that then affect the patient treatment journey?
Recent Videos
Related Content
